Skip to content

Clinical trials

Phase 1 Uterine Cervical Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 1 Country / region: China Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20102
20121
20173
20183
20195
20202
20212
202212
20238
20245
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status20
Recruiting14
Completed11
Active, not recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chongqing Precision Biotech Co., Ltd5
Huazhong University of Science and Technology3
Anhui Provincial Hospital2
Eli Lilly and Company2
HRYZ Biotech Co.2
Shanghai Zerun Biotechnology Co.,Ltd2
Xiamen University2
Adcentrx Therapeutics1
BGI, China1
Beijing Health Guard Biotechnology, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms49
Ovarian Neoplasms14
Neoplasm Metastasis9
Squamous Cell Carcinoma of Head and Neck7
Carcinoma, Non-Small-Cell Lung6
Carcinoma, Renal Cell6
Lung Neoplasms6
Vulvar Neoplasms6
Anus Neoplasms5
Vaginal Neoplasms5

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.